NCT00305903View on ClinicalTrials.gov

Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

August 31, 2007

Conditions
Alzheimer's Disease
Interventions
DRUG

Rivastigmine, memantine

Trial Locations (1)

08759

Paterson

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY